An mTORC1-to-CDK1 Switch Maintains Autophagy Suppression during Mitosis
Richard I Odle1, Simon A Walker2, David Oxley3
1Signalling Laboratory, The Babraham Institute, Babraham Research Campus, Cambridge CB22 3AT, UK.
Molecular Cell
|November 18, 2019
Summary
Macroautophagy initiation is repressed during mitosis. Cell division kinase 1 (CDK1) directly inhibits macroautophagy by phosphorylating key regulators, overriding nutrient signaling to maintain genome integrity.
Area of Science:
- Cell Biology
- Molecular Biology
- Autophagy Research
Background:
- Nuclear envelope breakdown during mitosis suggests macroautophagy inhibition is necessary for genome integrity.
- The mechanism of mitotic macroautophagy repression is not fully understood, with CDK1 phosphorylation of VPS34 being a proposed but unconfirmed pathway.
Purpose of the Study:
- To investigate the regulation of macroautophagy during mitosis.
- To elucidate the molecular mechanisms controlling macroautophagy initiation in dividing cells.
Main Methods:
- Monitoring ULK complex translocation to autophagic puncta as a measure of macroautophagy initiation.
- Assessing mTORC1 localization and activity during mitosis.
- Analyzing the phosphorylation status of autophagy regulators (ULK1, ATG13, ATG14, TFEB) during mitosis.
- Investigating the role of CDK1 and mTORC1 in regulating these phosphorylation events.
Main Results:
- Macroautophagy initiation is repressed during mitosis, irrespective of mTORC1 inhibition.
- mTORC1 is inactive during mitosis due to CDK1-dependent RAPTOR phosphorylation, preventing lysosomal localization.
- CDK1, not mTORC1, directly phosphorylates key autophagy regulators (ULK1, ATG13, ATG14, TFEB) at repressive sites during mitosis.
Conclusions:
- CDK1 acts as the master regulator of macroautophagy during mitosis, substituting for the inactive mTORC1.
- Mitotic autophagy repression is uncoupled from nutrient status, ensuring genome integrity through CDK1-mediated inhibition.
Related Concept Videos
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
M-Cdk Drives Transition Into Mitosis
6.2K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
6.2K
Anaphase Promoting Complex
3.3K
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
3.3K
PI3K/mTOR/AKT Signaling Pathway
5.2K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.2K
Separation of Sister Chromatids
4.3K
At the transition from prophase to metaphase, there is a reduction in cohesion along the chromosomal arms, resulting in the resolution of sister chromatids. However, residual cohesin connections remain to hold the sister chromatids together until the transition from metaphase to anaphase. The residual connection prevents any premature separation of sister chromatids, blocking the risks of aneuploidy within the daughter cells.
At the onset of anaphase, separase, a proteolytic enzyme, is...
At the onset of anaphase, separase, a proteolytic enzyme, is...
4.3K
Positive Regulator Molecules
6.4K
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
6.4K


